Compounds > re 1492
Page last updated: 2024-11-08

re 1492

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RE 1492: improves storage of whole blood & red blood cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163878
CHEMBL ID1970699
MeSH IDM0183796

Synonyms (13)

Synonym
re 1492
NCI60_037316
nsc-704565
nsc704565
112169-14-9
n,n',n''-tris(4-phenylbutyl)benzene-1,3,5-trimethanamine
n-[[3,5-bis[(4-phenylbutylamino)methyl]phenyl]methyl]-4-phenylbutan-1-amine
1,3,5-benzenetrimethanamine, n,n',n''-tris(4-phenylbutyl)-
re-1492
CHEMBL1970699
DTXSID10149934
n,n',n''-(benzene-1,3,5-triyltris(methylene))tris(4-phenylbutan-1-amine)
AKOS040747362

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In the same dosage the NO-donor RE 2047 (3-methyl-N-nitroso-sydnone-5-imine) produced an inhibition of 21-27%."( Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVII. Inhibition of leucocyte adherence to endothelium by the oligoamine RE 1492C and the NO-donor RE 2047.
Ciborski, T; Müller, B; Rehse, K, 1995)		0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.24 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index22.26 (26.88)
Search Engine Supply Index2.80 (0.95)

This Compound (22.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
3-methylsydnone-5-nitrosimine
3-methylsydnone-5-nitrosimine: structure given in first source		1.9810
ConditionIndicatedRelationship StrengthStudiesTrials
Extravascular Hemolysis
[description not available]		02.6730
Hemolysis
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.		07.6730